Webinar 1 – Foundations of hepatitis C and advanced liver disease
WHEN: 2 September 2026, 6:30pm- 8:00pm (AEST)
Learn about identifying key populations, testing indicators, and epidemiology around hepatitis C, as well as an overview on the impact of unmanaged viral hepatitis on the development of fibrosis and advanced liver disease.
Webinar 2 – Exploring hepatitis B and D in primary care
WHEN: 14 October 2026, 7:00 – 8:30pm (AEDT)
In this continuation from the first webinar, this session will demonstrate how national viral hepatitis guidelines and decision-making tools can be utilised in practice across testing, management, treatment, and referral pathways. Incorporating guidance and case studies on hepatitis B and D, this series conclusion provides a comprehensive summary of the key considerations for primary care workers when it comes to viral hepatitis management.
To get the most out of this course, it is highly recommended that you attend both webinars in the series. However, you are still able to register for one if you are unable to attend the other.
Endorsement and CPD:
Endorsement for both activities are currently pending with RACGP and ACRRM. These activities may be suitable for self-claiming CPD hours with your professional body. An estimated equivalent of 1.5 CPD hours for each webinar applies. A statement of attendance will be provided for full attendees.
Hepatitis B s100 prescribers completing the second webinar will also earn one hepatitis B s100 Prescriber Point.
This course is sponsored by Gilead and AbbVie. Sponsorship is provided in accordance with the ASHM’s Sponsorship Policy. ASHM does not endorse or promote any sponsor’s product or service.
Contact: education@ashm.org.au or 0431 320 429
REGISTRATION: https://ashm.org.au/education/viral-hepatitis-in-primary-care-webinar-series/